DYNAVAX

Dynavax Technologies Corporation

Application Filed: 2003-04-23
Trademark Application Details
Trademark Logo DYNAVAX

Mark For: DYNAVAX® trademark registration is intended to cover the categories of pharmaceutical and biological research, testing and product development consultation; pharmaceutical and biological research, testing and product development for others; vaccine research and development. [all]

Status

2022-02-10 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number76540616
Registration Number3307735
Mark Literal ElementsDYNAVAX
Mark Drawing Type1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark TypeSERVICE MARK
Standard Character ClaimNo
RegisterPRINCIPAL
Affidavit TextSECT 15. SECT 8 (6-YR). SECTION 8(10-YR) 20161231.
Affidavit Text1ST RENEWAL 20161231
Current LocationGENERIC WEB UPDATE 2016-12-31
Basis1(a)
Class StatusACTIVE
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
Primary International Class
  • 042 - Primary Class
  • (Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed UseNo
Current UseYes
Intent To UseNo
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameBeth M. Goldman
Attorney Docket Number21557-1
Law Office AssignedL60
Employee NameWILLIS, PAMELA Y

Timeline

1999-12-17Date of First Use
1999-12-17Date of Use In Commerce
1ST RENEWAL 20161231Renewal Date
2003-04-23Application Filed
2003-12-23Published
2003-12-23Published for Opposition
2007-10-09Trademark Registered
2016-12-31Location: GENERIC WEB UPDATE
2016-12-31Status: Live/Registered
2016-12-31Status: The registration has been renewed.
2017-10-09Renewal Date
2018-07-08Transaction Date
2026-10-09Maintenance Early File Date
2027-10-12Maintenance On Time Date
2028-04-10Maintenance Late Fee Date

Trademark Parties (Applicants & Owners)

Party: Dynavax Technologies Corporation
Address2100 Powell Street Suite 900 Emeryville, CALIFORNIA UNITED STATES 94608
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Attorney of Record

Beth M. Goldman
ORRICK, HERRINGTON & SUTCLIFFE LLP
IP Prosecution Department
2050 MAIN STREET, SUITE 1100
IRVINE CA 92614-8255

Good, Services, and Codes


IC 042. US 100 101. G & S: Pharmaceutical and biological research, testing and product development consultation; pharmaceutical and biological research, testing and product development for others; vaccine research and development. FIRST USE: 19991217. FIRST USE IN COMMERCE: 19991217

International Codes:42
U.S. Codes:100,101
Type CodeType
GS0421Pharmaceutical and biological research, testing and product development consultation; pharmaceutical and biological research, testing and product development for others; vaccine research and development

Trademark Filing History

DescriptionDateProceeding Number
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2020-03-10
TEAS CHANGE OF OWNER ADDRESS RECEIVED2020-03-10
TEAS CHANGE OF CORRESPONDENCE RECEIVED2020-03-10
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2020-03-10
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2020-03-1088888
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)2016-12-3175184
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED2016-12-3175184
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED2016-12-31
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2016-12-3175184
TEAS SECTION 8 & 9 RECEIVED2016-10-20
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED2016-10-09
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED2013-09-17
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.2013-09-1668335
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2013-09-1668335
TEAS SECTION 8 & 15 RECEIVED2013-09-04
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED2013-09-0468335
TEAS CHANGE OF CORRESPONDENCE RECEIVED2011-08-22
TEAS CHANGE OF CORRESPONDENCE RECEIVED2008-11-04
REGISTERED-PRINCIPAL REGISTER2007-10-09
LAW OFFICE REGISTRATION REVIEW COMPLETED2007-09-0478413
ASSIGNED TO LIE2007-09-0478413
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2007-07-25
STATEMENT OF USE PROCESSING COMPLETE2007-06-1976984
USE AMENDMENT FILED2007-03-1476984
TEAS STATEMENT OF USE RECEIVED2007-03-14
TEAS EXTENSION RECEIVED2006-08-21
EXTENSION 5 GRANTED2006-08-2198765
EXTENSION 5 FILED2006-08-2198765
TEAS EXTENSION RECEIVED2006-03-15
EXTENSION 4 GRANTED2006-03-1598765
EXTENSION 4 FILED2006-03-1598765
EXTENSION 3 GRANTED2005-08-2264657
TEAS EXTENSION RECEIVED2005-08-16
EXTENSION 3 FILED2005-08-1664657
EXTENSION 2 GRANTED2005-03-2876874
TEAS EXTENSION RECEIVED2005-03-03
EXTENSION 2 FILED2005-03-0376874
TEAS EXTENSION RECEIVED2004-08-11
EXTENSION 1 GRANTED2004-08-11
EXTENSION 1 FILED2004-08-11
NOA MAILED - SOU REQUIRED FROM APPLICANT2004-03-16
PUBLISHED FOR OPPOSITION2003-12-23
NOTICE OF PUBLICATION2003-12-03
ASSIGNED TO EXAMINER2003-09-2576151
APPROVED FOR PUB - PRINCIPAL REGISTER2003-09-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed